Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG37301

KIF3B Knockout Hela Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Uterus (cervix)

  • Disease:

    Adenocarcinoma

The KIF3B Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population with disruption of the KIF3B gene in HeLa cells. KIF3B, the motor subunit of kinesin-2, drives anterograde intraflagellar transport and is essential for ciliogenesis and Hedgehog signaling, interacting with KIF3A, KAP3, and IFT complex B proteins. This loss-of-function model is ideal for studying ciliary assembly, intracellular trafficking, and ciliary-dependent pathways in a cervical cancer context. Applications include immunofluorescence analysis of cilia, GLI reporter assays, live imaging of IFT, and drug screening for ciliary modulators.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HeLa

    Sex of Donor

    Female

    Age

    31 years

    Gene Name

    KIF3B

    Gene Identifier

    NCBI Gene ID 9371

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The KIF3B Knockout HeLa Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population designed to disrupt the human KIF3B gene in HeLa cells, creating a robust loss-of-function model for dissecting kinesin-2-dependent processes. This polyclonal pool is generated through CRISPR/Cas9-mediated gene disruption, providing a heterogeneous mixture of knockout alleles that avoids the ackgroundred drift associated with single-cell clones and enables functional studies in a bulk population. As a polyclonal knockout product, it is particularly suited for researchers investigating ciliary biology and intracellular transport without the confounding influence of clonal variation.

The host HeLa cell line, derived from a HPV18-positive cervical adenocarcinoma, is an immortalized, adherent epithelial line widely employed as a model for human cell biology. HeLa cells exhibit robust growth characteristics and are amenable to a diverse array of genetic manipulations, making them a versatile chassis for studying gene function. Under appropriate conditions, such as serum starvation, HeLa cells are capable of ciliogenesis, thereby providing a tractable system to examine cilia assembly and associated signaling pathways.

KIF3B encodes the motor subunit of the heterotrimeric kinesin-2 complex, which also includes the motor partner KIF3A and the adaptor protein KAP3 (KIFAP3). This motor complex drives anterograde intraflagellar transport (IFT) along microtubules, a process essential for ciliogenesis and the trafficking of cargo within cilia and cytoplasm. KIF3B expression is regulated transcriptionally by FOXJ1 and RFX3, and its activity can be modulated by Aurora A kinase and serum starvation. The kinesin-2 complex interacts with IFT-B proteins, including IFT88 and IFT20, as well as the dynactin component p150Glued, to transport ciliary cargo such as the Hedgehog signaling components SMO and GLI transcription factors (GLI2). Consequently, KIF3B is a critical node linking motor-driven transport to ciliary assembly and Hedgehog-responsive transcriptional outputs.

Knockout of KIF3B in HeLa cells disrupts kinesin-2 motor function, leading to defective ciliogenesis and impaired ciliary-dependent signaling, including the Hedgehog and Wnt pathways. Given the HPV-positive cervical cancer origin, this polyclonal knockout model provides a unique platform to explore the interplay between oncogenic transformation and ciliary dysfunction. The heterogeneous knockout population recapitulates the variability seen in tumor contexts and is valuable for studying how loss of KIF3B affects cellular processes such as proliferation, migration, and signaling in a cancer-relevant background.

This product is well-suited for a broad range of experimental applications. Researchers can employ immunofluorescence staining with acetylated tubulin to assess cilia formation, Western blotting to confirm KIF3B depletion, and RT-qPCR to measure expression of ciliary target genes. Live imaging of GFP-tagged IFT particles enables direct visualization of transport defects, while GLI-luciferase reporter assays quantify Hedgehog pathway activity. Additionally, wound healing migration assays can be used to investigate the role of KIF3B in cell motility. This model is also appropriate for drug screening campaigns aiming to identify modulators of ciliogenesis or ciliary signaling. For additional information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)